Other observed topics

dose

Observed in 115 articles across 31 journals.

Steady

Latest share0.22%

Change vs baseline-0.04 pp

Months observed13

Latest monthJul 2026

Portfolio article share

Attention over this snapshot

13 monthly points

Journal breadth

Where it appears

Journal for ImmunoTherapy of Cancer40
European Journal of Hospital Pharmacy15
BMJ Open8
Heart8
Gut5
Lupus Science & Medicine4
BMJ Supportive & Palliative Care3
Journal of NeuroInterventional Surgery3
Thorax3
BMJ Case Reports2
Journal of Neurology, Neurosurgery & Psychiatry2
Journal of Scleroderma and Related Disorders2

Co-occurrence

Explore nearby topics

Inspect the source signal

Article evidence

30 high-ranking examples

Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26

35 Steroid-sparing agent initiation in myasthenia gravis

Phrase rank #2 · DOI 10.1136/jnnp-2025-ABN.35

Journal for ImmunoTherapy of Cancer · 2025-11-04

530 CD40 agonist mitazalimab + mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma: dose characterization based on exposure response and biomarker analysis from the OPTIMIZE-1 study

Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0530

Journal of Scleroderma and Related Disorders · 2026-06-05

P.271 MTX-474 appears safe and well tolerated, engages its target, EphrinB2, and impacts pharmacodynamic biomarkers in healthy volunteers

Phrase rank #3 · DOI 10.1136/JSRD-2026-SSWC.314

BMJ Open · 2026-05-04

Optimal dose and type of exercise across cardiometabolic outcomes in adults with overweight or obesity: protocol for a Bayesian model-based dose–response network meta-analysis of randomised controlled trials

Phrase rank #3 · DOI 10.1136/bmjopen-2025-113896

European Journal of Hospital Pharmacy · 2026-03-18

3PC-023 Simulation of dose banding implementation in the preparation of anticancer drugs

Phrase rank #3 · DOI 10.1136/ejhpharm-2026-eahp.86

Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26

184 Dose adjustments of lamotrigine during pregnancy and the postpartum period

Phrase rank #3 · DOI 10.1136/jnnp-2025-ABN.184

Journal for ImmunoTherapy of Cancer · 2025-11-04

1055 Flat toxicity curve across PD-1/PD-L1 inhibitor dose densities: meta-analysis supports dose de-escalation without increased immune-related adverse event risk

Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.1055

Journal for ImmunoTherapy of Cancer · 2025-11-04

532 A phase 1 dose escalation and dose expansion trial of NP-101 in patients with advanced solid tumors

Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0532

Journal for ImmunoTherapy of Cancer · 2025-11-04

615 Phase 1 study of intratumoral VAX014 with dose expansion in combination with pembrolizumab or nivolumab in patients with advanced solid tumors

Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0615

BMJ Evidence-Based Medicine · 2025-09-02

083 The need for inhalers to have dose counters: an observational study in Edmonton, Alberta, Canada

Phrase rank #3 · DOI 10.1136/EBM-2025-POD.83

Journal for ImmunoTherapy of Cancer · 2026-05-04

Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer

Phrase rank #4 · DOI 10.1136/jitc-2025-014314

European Journal of Hospital Pharmacy · 2026-04-23

Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin

Phrase rank #4 · DOI 10.1136/ejhpharm-2024-004452

Journal for ImmunoTherapy of Cancer · 2025-11-07

1339 A randomized, double-blind, placebo-controlled, dose-escalated, first-in-human study to assess the safety, tolerability, and T cell replenishment of JL18008, a long-acting IL-7, in healthy subjects

Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.1339

Journal for ImmunoTherapy of Cancer · 2025-11-04

583 Intrathecal PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from solid tumors: preliminary results from a phase I/II study (NCT 06462222)

Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0583

Journal for ImmunoTherapy of Cancer · 2025-11-04

573 Phase 1 study of GEN2, a personalizing systemic cancer immunotherapy, in adult patients with advanced solid tumor malignancies

Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0573

Journal for ImmunoTherapy of Cancer · 2025-11-04

567 XTX301, a tumor-activated Interleukin-12 (IL-12), demonstrated IL-12 pharmacology in patients with advanced solid tumors: pharmacodynamic data from first-in-human phase 1 study (NCT05684965)

Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0567

Journal for ImmunoTherapy of Cancer · 2025-11-04

520 Safety and tolerability of ASP1012, an oncolytic virus, in adults with locally advanced or metastatic solid tumors: Results from a first-in-human, phase 1, open-label, dose-escalation study

Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0520

Thorax · 2025-11-02

P28 Little women looking into antifibrotic tolerance in relation to weight, dose, female gender and ethnicity

Phrase rank #4 · DOI 10.1136/thorax-2025-BTSabstracts.210

Heart · 2026-06-24

36 CT coronary angiography radiation output and subjective image quality across scanner generations, from 2019 to 2025

Phrase rank #5 · DOI 10.1136/heartjnl-2026-BSCI.36

European Journal of Hospital Pharmacy · 2026-03-18

4CPS-303 Dose reduction of ibrutinib in chronic lymphocytic leukaemia: real-world experience in a primary hospital

Phrase rank #5 · DOI 10.1136/ejhpharm-2026-eahp.400

Open Heart · 2026-03-06

Prognostic impact of corticosteroid maintenance dose and re-escalation in patients with cardiac sarcoidosis

Phrase rank #5 · DOI 10.1136/openhrt-2026-004048

Journal for ImmunoTherapy of Cancer · 2025-11-04

561 A Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of TNG260 in combination with pembrolizumab in patients with STK11-mutated advanced solid tumors

Phrase rank #5 · DOI 10.1136/jitc-2025-SITC2025.0561

Journal of NeuroInterventional Surgery · 2025-09-02

A58 Radiation dose reduction with ultra-low dose photon-counting CT for adult ventriculoperitoneal shunt assessment compared to conventional X-ray

Phrase rank #5 · DOI 10.1136/jnis-2025-ESMINT.41

BMJ Open Respiratory Research · 2025-07-31

Temporal complexity in missed doses of rifampicin-sensitive anti-tuberculosis treatment: a prospective cohort study in Tanzania

Phrase rank #5 · DOI 10.1136/bmjresp-2024-003088

BMJ Open · 2026-07-08

Safety and early efficacy of iPSC-derived motor neuron progenitor cells in subacute spinal cord injury: protocol for a phase I, multicentre, open-label, single-arm trial

Phrase rank #6 · DOI 10.1136/bmjopen-2025-111718

Gut · 2026-06-23

P254 Real-world outcomes of upadacitinib dose escalation in inflammatory bowel disease

Phrase rank #6 · DOI 10.1136/gutjnl-2026-BSG.370

Journal for ImmunoTherapy of Cancer · 2026-02-11

Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors

Phrase rank #6 · DOI 10.1136/jitc-2025-012377

Practical Neurology · 2025-11-13

Carphology

Phrase rank #6 · DOI 10.1136/pn-2025-004923

Stroke and Vascular Neurology · 2025-11-10

Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial

Phrase rank #6 · DOI 10.1136/svn-2025-004581

Journal for ImmunoTherapy of Cancer · 2025-11-04

589 A first in human clinical trial to assess the anti-IL18BP antibody, COM503 (GS-0321) in participants with advanced solid malignancies

Phrase rank #6 · DOI 10.1136/jitc-2025-SITC2025.0589